Our state-of-the-art plant is cGMP-certified and has been licensed by the Belgium Regulatory Agency for the manufacturing of ATMP products. The 1200m2 space is set up to manage multiple production and development projects simultaneously. The facility is designed for both clinical and commercial production.
CureCell (MaSTherCell Korea) is a Korean based company with a particular focus on developing innovative regenerative therapies for both the Korean and international markets. Together, with promising in-house research programs, the foreign technologies are currently under development for fastest growing Asian market well beyond the Korean market offering the most favorable environment for the regenerative medicine industry in the world. Through close collaboration with leading medical and academic facilities, CureCell is accelerating the development of foreign technologies in Korea and is well positioned in expanding international markets for Korean technologies. Orgenesis and CureCell created a Joint Venture for Contract Development and Manufacturing of Cell Therapy Products in South Korea.
Atvio-Biotech (Part of the MasTherCell Global network) is a specialized process and product development firm focused on costume-made process development, upscaling design from lab to industry innovation and automation procedures, which are extremely essential in the cell therapy industry. The company is located in Bar-Lev Industrial Park utilizing the exclusive Israeli innovative ecosystem and highly experienced and talented associates including PhD holders and Biotechnology engineers. The center provides end to end solutions to cell therapy industries, process development capabilities and proficiency, custom-made engineering and a unique platform for creative design and process optimization.
The company spreads over 1300 sqm2 of labs and offices resulting in an efficient and unique environment for cell therapy development.